海峡药学
海峽藥學
해협약학
STRAIT PHARMACEUTICAL JOURNAL
2015年
5期
239-242
,共4页
林接玉%付明娟%许春森%谢捷明
林接玉%付明娟%許春森%謝捷明
림접옥%부명연%허춘삼%사첩명
人类表皮生长因子受体2%曲妥珠单抗%南瓜蛋白%免疫毒素
人類錶皮生長因子受體2%麯妥珠單抗%南瓜蛋白%免疫毒素
인류표피생장인자수체2%곡타주단항%남과단백%면역독소
Human epidermal growth factor receptor-2%Trastuzumab%Cucurmosin%Immunetoxin
目的:制备由抗人类表皮生长因子受体2(HER-2/NEU)单克隆抗体曲妥珠单抗(Trastuzumab,简称 T)与南瓜蛋白(Cucurmosin,简称CUS)偶联而成的免疫毒素,并进行鉴定。方法以N-琥珀酰胺-3-(2-吡啶二硫)丙酸酯( SPDP)为偶联剂,制备 T-CUS,经过Ni Sepharose 6 Fast Flow和SP Sepharose 6 Fast Flow纯化后SDS-PAGE分析其纯度及成分,细胞ELISA法检测其对人乳腺癌BT-474细胞的结合能力。结果 SDS-PAGE分析显示T-CUS免疫毒素成功构建,免疫毒素基本保留了对BT-474细胞的结合能力。结论利用SPDP可实现曲妥珠单抗与CUS的成功偶联。
目的:製備由抗人類錶皮生長因子受體2(HER-2/NEU)單剋隆抗體麯妥珠單抗(Trastuzumab,簡稱 T)與南瓜蛋白(Cucurmosin,簡稱CUS)偶聯而成的免疫毒素,併進行鑒定。方法以N-琥珀酰胺-3-(2-吡啶二硫)丙痠酯( SPDP)為偶聯劑,製備 T-CUS,經過Ni Sepharose 6 Fast Flow和SP Sepharose 6 Fast Flow純化後SDS-PAGE分析其純度及成分,細胞ELISA法檢測其對人乳腺癌BT-474細胞的結閤能力。結果 SDS-PAGE分析顯示T-CUS免疫毒素成功構建,免疫毒素基本保留瞭對BT-474細胞的結閤能力。結論利用SPDP可實現麯妥珠單抗與CUS的成功偶聯。
목적:제비유항인류표피생장인자수체2(HER-2/NEU)단극륭항체곡타주단항(Trastuzumab,간칭 T)여남과단백(Cucurmosin,간칭CUS)우련이성적면역독소,병진행감정。방법이N-호박선알-3-(2-필정이류)병산지( SPDP)위우련제,제비 T-CUS,경과Ni Sepharose 6 Fast Flow화SP Sepharose 6 Fast Flow순화후SDS-PAGE분석기순도급성분,세포ELISA법검측기대인유선암BT-474세포적결합능력。결과 SDS-PAGE분석현시T-CUS면역독소성공구건,면역독소기본보류료대BT-474세포적결합능력。결론이용SPDP가실현곡타주단항여CUS적성공우련。
OBJECTIVE To prepare an immunotoxin ( IT) by coupling the monoclonal antibody against human epidermal growth factor receptor ( HER-2/NEU) to Cucurmosin( CUS) ,then identify.METHODS T-CUS was pre-pared using N-succinimidyl-3-(2-pyridyldithio)-propionate ( SPDP) as a coupler,and was purified using Ni Sepha-rose 6 Fast Flow column and SP Sepharose 6 Fast Flow column, then analyzed for purity and component by SDS-PAGE,and determined for binding ability to human breast cancer BT-474 cells by ELISA.RESULTS SDS-PAGE showed that T-CUS was successfully constructed,and the binding ability of human breast cancer BT-474 cells was ba-sically retained.CONCLUSION Trastuzumab may be successfully coupled to CUS by using SPDP.